• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

miR-492 通过靶向 SOX7 对卵巢癌细胞迁移、侵袭、上皮间质转化及预后的影响

Effects of miR-492 on migration, invasion, EMT and prognosis in ovarian cancer by targeting SOX7.

机构信息

Department of Reproductive Genetics, Liaocheng People's Hospital, Liaocheng 252000, China.

出版信息

J BUON. 2020 Mar-Apr;25(2):797-804.

PMID:32521870
Abstract

PURPOSE

Ovarian cancer (OC) is one of the most common malignancies in females with high mortality rate. MicroRNAs (miRNAs or miRs) serve as oncogenes or tumor suppressors in various human cancer types, including OC. The aim of this study was to explore the roles of miR-492 in OC.

METHODS

Two human ovarian cancer cell lines, SKOV3 and CAOV3, and a normal ovarian cell line IOSE80 were used in this study. Real-time quantitative polymerase chain reaction (RT-qPCR) was conducted to measure the mRNA levels of miRNAs and genes. The protein levels of epithelial-mesenchymal transition (EMT) associated genes were calculated using Western blot. Transwell assay was utilized to evaluate the migratory and invasive capacities.

RESULTS

MiR-492 was overexpressed while SRY-box 7 (SOX7) was lowly expressed in OC tissues and cells. Upregulation of miR-492 or downregulation of SOX7 predicted poor prognosis of OC patients. MiR-492 regulated the expression of SOX7 via directly binding to the 3'-untranslated region (3'-UTR) of SOX7 mRNA in SKOV3 OC cells. The expression of miR-492 had a negative relationship with SOX7 in OC tissues. MiR-492 promoted the migration, invasion and EMT through SOX7 in SKOV3 cells. SOX7 could partially reverse the role of miR-492 on the migratory, invasive and EMT abilities in SKOV3 cells.

CONCLUSIONS

MiR-492 promoted the migratory, invasive and EMT abilities through SOX7 in OC. This suggested that miR-492/SOX7 axis may be an effective candidate therapeutic target for the treatment of OC.

摘要

目的

卵巢癌(OC)是女性中最常见的恶性肿瘤之一,死亡率很高。 microRNAs(miRNAs 或 miRs)在包括 OC 在内的多种人类癌症类型中充当癌基因或肿瘤抑制因子。本研究旨在探讨 miR-492 在 OC 中的作用。

方法

本研究使用了两种人卵巢癌细胞系 SKOV3 和 CAOV3 以及正常卵巢细胞系 IOSE80。实时定量聚合酶链反应(RT-qPCR)用于测量 miRNA 和基因的 mRNA 水平。使用 Western blot 计算上皮-间充质转化(EMT)相关基因的蛋白水平。Transwell 测定用于评估迁移和侵袭能力。

结果

miR-492 在 OC 组织和细胞中高表达,而 SRY-box 7(SOX7)低表达。miR-492 的上调或 SOX7 的下调预示着 OC 患者的预后不良。miR-492 通过直接结合 SOX7 mRNA 的 3'-非翻译区(3'-UTR)来调节 SKOV3 OC 细胞中 SOX7 的表达。miR-492 在 OC 组织中与 SOX7 的表达呈负相关。miR-492 通过 SOX7 促进 SKOV3 细胞的迁移、侵袭和 EMT。SOX7 可部分逆转 miR-492 对 SKOV3 细胞迁移、侵袭和 EMT 能力的作用。

结论

miR-492 通过 SOX7 促进 OC 中的迁移、侵袭和 EMT 能力。这表明 miR-492/SOX7 轴可能是治疗 OC 的有效候选治疗靶点。

相似文献

1
Effects of miR-492 on migration, invasion, EMT and prognosis in ovarian cancer by targeting SOX7.miR-492 通过靶向 SOX7 对卵巢癌细胞迁移、侵袭、上皮间质转化及预后的影响
J BUON. 2020 Mar-Apr;25(2):797-804.
2
MiR-137 and miR-34a directly target Snail and inhibit EMT, invasion and sphere-forming ability of ovarian cancer cells.微小RNA-137和微小RNA-34a直接靶向蜗牛蛋白,并抑制卵巢癌细胞的上皮-间质转化、侵袭和球体形成能力。
J Exp Clin Cancer Res. 2016 Sep 5;35(1):132. doi: 10.1186/s13046-016-0415-y.
3
Overexpression of miR-664 is associated with enhanced osteosarcoma cell migration and invasion ability via targeting SOX7.miR-664的过表达通过靶向SOX7与骨肉瘤细胞迁移和侵袭能力增强相关。
Clin Exp Med. 2017 Feb;17(1):51-58. doi: 10.1007/s10238-015-0398-6. Epub 2015 Oct 29.
4
LINC-PINT suppresses tumour cell proliferation, migration and invasion through targeting miR-374a-5p in ovarian cancer.LINC-PINT 通过靶向 miR-374a-5p 抑制卵巢癌细胞的增殖、迁移和侵袭。
Cell Biochem Funct. 2020 Dec;38(8):1089-1099. doi: 10.1002/cbf.3565. Epub 2020 Jul 7.
5
MicroRNA-494-3p Promotes Cell Growth, Migration, and Invasion of Nasopharyngeal Carcinoma by Targeting Sox7.微小RNA-494-3p通过靶向Sox7促进鼻咽癌细胞的生长、迁移和侵袭。
Technol Cancer Res Treat. 2018 Jan 1;17:1533033818809993. doi: 10.1177/1533033818809993.
6
MiR-9 is involved in TGF-β1-induced lung cancer cell invasion and adhesion by targeting SOX7.微小RNA-9通过靶向SOX7参与转化生长因子-β1诱导的肺癌细胞侵袭和黏附。
J Cell Mol Med. 2017 Sep;21(9):2000-2008. doi: 10.1111/jcmm.13120. Epub 2017 Mar 7.
7
MiR-99a suppressed cell proliferation and invasion by directly targeting HOXA1 through regulation of the AKT/mTOR signaling pathway and EMT in ovarian cancer.微小RNA-99a通过调控AKT/mTOR信号通路和上皮间质转化直接靶向同源盒A1,从而抑制卵巢癌细胞的增殖和侵袭。
Eur Rev Med Pharmacol Sci. 2019 Jun;23(11):4663-4672. doi: 10.26355/eurrev_201906_18046.
8
MiR-29c-3p, a target miRNA of LINC01296, accelerates tumor malignancy: therapeutic potential of a LINC01296/miR-29c-3p axis in ovarian cancer.miR-29c-3p,LINC01296 的一个靶 miRNA,加速肿瘤恶性进展:LINC01296/miR-29c-3p 轴在卵巢癌中的治疗潜力。
J Ovarian Res. 2020 Mar 19;13(1):31. doi: 10.1186/s13048-020-00631-w.
9
MiR-574-3p exerts as a tumor suppressor in ovarian cancer through inhibiting MMP3 expression.miR-574-3p 通过抑制 MMP3 表达在卵巢癌中发挥肿瘤抑制作用。
Eur Rev Med Pharmacol Sci. 2019 Aug;23(16):6839-6848. doi: 10.26355/eurrev_201908_18723.
10
MiR-1294 confers cisplatin resistance in ovarian Cancer cells by targeting IGF1R.miR-1294 通过靶向 IGF1R 赋予卵巢癌细胞顺铂耐药性。
Biomed Pharmacother. 2018 Oct;106:1357-1363. doi: 10.1016/j.biopha.2018.07.059. Epub 2018 Jul 23.

引用本文的文献

1
hsa_circ_0129047 Upregulates LYVE1 to Inhibit Hepatocellular Carcinoma Progression by Sponging miR-492.hsa_circ_0129047 通过海绵吸附 miR-492 上调 LYVE1 抑制肝细胞癌进展。
Dis Markers. 2023 Sep 30;2023:6978234. doi: 10.1155/2023/6978234. eCollection 2023.
2
An EMT-related genes signature as a prognostic biomarker for patients with endometrial cancer.一个 EMT 相关基因标志物作为子宫内膜癌患者的预后生物标志物。
BMC Cancer. 2023 Sep 18;23(1):879. doi: 10.1186/s12885-023-11358-4.
3
miR-146a Inhibited Pancreatic Cancer Cell Proliferation by Targeting SOX7.
miR-146a 通过靶向 SOX7 抑制胰腺癌细胞增殖。
J Healthc Eng. 2022 Feb 16;2022:2240605. doi: 10.1155/2022/2240605. eCollection 2022.
4
SOX9: Advances in Gynecological Malignancies.SOX9:妇科恶性肿瘤的进展
Front Oncol. 2021 Nov 22;11:768264. doi: 10.3389/fonc.2021.768264. eCollection 2021.
5
Circulating miRNAs in Serum as Biomarkers for Early Diagnosis of Non-small Cell Lung Cancer.血清中循环微小RNA作为非小细胞肺癌早期诊断的生物标志物
Front Genet. 2021 Jul 9;12:673926. doi: 10.3389/fgene.2021.673926. eCollection 2021.
6
Small Non-Coding-RNA in Gynecological Malignancies.妇科恶性肿瘤中的小非编码RNA
Cancers (Basel). 2021 Mar 3;13(5):1085. doi: 10.3390/cancers13051085.